Education
About Us
Working with TipRanks
Follow Us
Holista Colltech Limited (AU:HCT)
ASX:HCT
HCT Stock Chart & Stats
AU$0.09
<AU$0.01(10.00%)
At close: 4:00 PM EST
AU$0.09
<AU$0.01(10.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.11
Previous CloseN/A
Volume829.52K
Average Volume (3M)72.05K
Market Cap
AU$23.91M
Enterprise ValueAU$18.37M
Total Cash (Recent Filing)AU$2.16M
Total Debt (Recent Filing)AU$1.59M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding367,834,350
10 Day Avg. Volume123,924
30 Day Avg. Volume72,050
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)28.04
Price to Sales (P/S)5.45
P/FCF Ratio-20.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet ImprovementEquity turning positive in 2025 indicates a repaired capital base versus prior years, lowering insolvency risk and improving the firm's structural ability to raise funds or absorb losses. This enhances counterparties’ confidence and provides a firmer platform for medium-term recovery and partnerships.
Product/Technology DiversificationThe company's dual focus on branded ingestible wellness products and collagen-derived technologies creates diversified revenue pathways (direct consumer and B2B ingredient/technology supply). This structural mix can stabilize revenues over time and allows cross-selling and licensing opportunities if execution and commercial agreements scale.
Gross Margin RecoveryAn improved gross margin in 2025 signals progress on product mix or cost controls and suggests underlying unit economics are recovering. If sustained alongside revenue stabilization, higher gross margins provide a path to restore operating profitability and reduce reliance on external funding over the medium term.
Bears Say
Negative Cash GenerationPersistent negative operating and free cash flow, worsening in 2025, creates ongoing cash burn and financing dependency. Structurally weak cash generation limits ability to fund operations, invests in growth, or withstand shocks without dilutive or costly external financing, posing medium-term solvency and execution risks.
Sharp Revenue ContractionA dramatic revenue decline in 2025 undermines scale economics and the viability of existing commercial channels. Structural revenue deterioration makes it harder to absorb fixed costs, weakens negotiating leverage with partners, and increases the time and investment required to return to sustainable profitability.
Elevated LeverageHigh reported debt relative to modest equity amplifies financial risk and restricts flexibility. Elevated leverage increases interest and covenant pressure, limits capacity for strategic investments, and makes the company vulnerable to further revenue or margin shocks absent clear deleveraging or earnings improvement.
Holista Colltech Limited News
HCT FAQ
What was Holista Colltech Limited’s price range in the past 12 months?
Holista Colltech Limited lowest share price was AU$0.02 and its highest was AU$0.11 in the past 12 months.
What is Holista Colltech Limited’s market cap?
Holista Colltech Limited’s market cap is AU$23.91M.
When is Holista Colltech Limited’s upcoming earnings report date?
Holista Colltech Limited’s upcoming earnings report date is Aug 28, 2026 which is in 169 days.
How were Holista Colltech Limited’s earnings last quarter?
Holista Colltech Limited released its earnings results on Feb 27, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Holista Colltech Limited overvalued?
According to Wall Street analysts Holista Colltech Limited’s price is currently Overvalued.
Does Holista Colltech Limited pay dividends?
Holista Colltech Limited does not currently pay dividends.
What is Holista Colltech Limited’s EPS estimate?
Holista Colltech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Holista Colltech Limited have?
Holista Colltech Limited has 367,834,350 shares outstanding.
What happened to Holista Colltech Limited’s price movement after its last earnings report?
Holista Colltech Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.11%.
Which hedge fund is a major shareholder of Holista Colltech Limited?
Currently, no hedge funds are holding shares in AU:HCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Holista Colltech Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
212.00%
12-Months-Change
Fundamentals
Return on Equity
-321.20%
Trailing 12-Months
Asset Growth
72.50%
Trailing 12-Months
Company Description
Holista Colltech Limited
Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar. The company also provides infection control solutions. Holista CollTech Limited is based in Subiaco, Australia.
Technical Analysis
Wellnex Life Ltd
―
EVE Health Group Limited
―
―
Forbidden Foods Ltd
―
Maggie Beer Holdings Ltd.
―